CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Delisting notice
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement · New debt or obligation
- NT 10-Q Other NT 10-Q
- 10-K Report Annual Report
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · New debt or obligation · Shareholder rights changed · Executive or director change · Other events
- 4 Shares withheld for taxes Pres., Functional Regeneration gave up 268 shares (to pay taxes)
- 4 Shares withheld for taxes Senior Exec Vice President gave up 583 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,182 shares (to pay taxes)
- SCHEDULE 13D Stake Beneficial Ownership Report
- NT 10-K Other NT 10-K
Page 2 of 29 · 563 filings